Subscribe To
Shield therapeutics appoints chief commercial officer as group readies for us sales offensive
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF), the developer of a breakthrough oral drug for iron deficiency, has announced the appointment of indu...
April 5, 2023, 2:47 am
Xph: revenue challenges ahead for u.s. pharmaceuticals
XPH gives you exposure to a broad-based cut of the US pharmaceuticals sector. Patent expirations are a ...
April 4, 2023, 11:52 pm
Johnson & johnson is again trying to use bankruptcy to settle talc cases for $8.9 billion
Johnson & Johnson is trying once again to use the bankruptcy courts to settle tens of thousands of cases that claim its talc products cause cancer. Th...
April 4, 2023, 6:52 pm
Salarius pharmaceuticals to present at the diamond equity research emerging growth invitational conference
HOUSTON, April 04, 2023 (GLOBE NEWSWIRE) -- Salarius pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-s...
April 4, 2023, 4:02 pm
Why shares of inovio pharmaceuticals were down tuesday
Inovio said it has enough cash to fund operations into the first quarter of 2025. The company focuses on DNA medicines to treat HPV diseases, cancer, ...
April 4, 2023, 3:10 pm
Vertex is 1 step closer to bringing a new blockbuster to market. time to buy?
Vertex pharmaceuticals is a top seller of cystic fibrosis treatments -- but it's about to expand into a...
April 4, 2023, 2:00 pm
Is adial pharmaceuticals (adil) stock outpacing its medical peers this year?
Here is how Adial pharmaceuticals, Inc. (ADIL) and Adverum Biotechnologies (ADVM) have performed compar...
April 4, 2023, 11:24 am
Wall street analysts think kalvista pharmaceuticals, inc. (kalv) could surge 145.98%: read this before placing a bet
The consensus price target hints at a 146% upside potential for KalVista pharmaceuticals, Inc. (KALV). ...
April 4, 2023, 11:24 am
Wall street analysts see a 128.83% upside in theseus pharmaceuticals, inc. (thrx): can the stock really move this high?
The average of price targets set by Wall Street analysts indicates a potential upside of 128.8% in Theseus pha...
April 4, 2023, 11:24 am
1 growth stock to buy before the next bull market
Catalyst pharmaceuticals expects improving results this year. Its new epilepsy medicine is likely to se...
April 4, 2023, 10:23 am
Voyageur pharmaceuticals reports positive comparative study of smoothx barium contrast media for ct imaging
Voyageur pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) said it has completed comparative studies of its Sm...
April 4, 2023, 9:19 am
Algernon pharmaceuticals announces successful dosing of second cohort in phase 1 dmt clinical study
Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its subsidiary Algernon NeuroScience (AGN Ne...
April 4, 2023, 7:46 am
Strength seen in apellis pharmaceuticals, inc. (apls): can its 16.3% jump turn into more strength?
Apellis pharmaceuticals, Inc. (APLS) witnessed a jump in share price last session on above-average trad...
April 4, 2023, 5:21 am
Regeneron to report first quarter 2023 financial and operating results and host conference call and webcast on may 4, 2023
TARRYTOWN, N.Y., April 03, 2023 (GLOBE NEWSWIRE) -- Regeneron pharmaceuticals, Inc. (NASDAQ: REGN) toda...
April 3, 2023, 4:00 pm
Here is what to know beyond why catalyst pharmaceuticals, inc. (cprx) is a trending stock
Catalyst (CPRX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the ...
April 3, 2023, 10:39 am
Respirerx pharmaceuticals highlights analogs of its anti-seizure treatment in scientific publications
RespireRx pharmaceuticals (OTC:RSPI) Inc has announced the publication of four articles describing the ...
April 3, 2023, 10:06 am
Apellis (apls) kindles acquisition interest per bloomberg
Per a Bloomberg article, Apellis pharmaceuticals (APLS) is considering a possible buyout by larger phar...
April 3, 2023, 9:07 am
Algernon pharma says wholly-owned subsidiary's reg a+ offering gets us sec qualification
Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its wholly-owned subsidiary, Algernon NeuroSc...
April 3, 2023, 7:54 am
Mgc pharma to develop and research new psilocybin medicines in europe
MGC pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has been given the greenlight to develop and rese...
April 3, 2023, 7:48 am
Why do we keep buying takeda pharmaceutical shares
Sales of Takhzyro amounted to 44.1 billion Japanese yen in the 3rd quarter of 2022, an increase of 42.7% from the previous year. Takeda ...
April 3, 2023, 3:51 am